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Over the last 20 years, interventional nephrology (IN) has
become a new and emerging subspecialty of nephrology. The
International Society of Nephrology has created an Interven-
tional Nephrology Committee to improve the overall quality of
patient care by promoting IN [1]. This has led to many young
nephrologists taking the initiative and performing percutaneous
endovascular procedures by themselves to avoid unnecessary
delays rather than consulting with a variety of specialists.
Financial data from the US Renal Data System suggest that
surgeons, radiologists, and nephrologists are responsible for
approximately 35%, 30%, and 25%, respectively, of vascular access
costs, with the balance being split between anesthesiology and
other specialties [2]. Since the establishment of the Korean Study
Group for Interventional Nephrology in 2010 which was
endorsed by the Korean Society of Nephrology in 2013, some
frontier nephrologists interested in IN have performed these
endovascular procedures in Korea. The study by Lee and Park [3]
reported for the ﬁrst time the effectiveness and safety of vascular
access procedures performed by interventional nephrologists in
Korea. The authors showed that the clinical success rate, primary
patency rate, and secondary patency rate at 3 months were
89.3%, 56.6%, and 85.7%, respectively. Notably, these results
exceeded the recommendations of the Kidney Disease Outcomes
Quality Initiative guidelines: a clinical success rate 485% and a
primary patency rate at 3 months 440%. However, the success
rate of the current study was not conclusive as it did not establish
the effectiveness and/or superiority of endovascular interventions
by nephrologists according to a large series, showing a clinical
success rate 495% by nephrologists in the US as well as by
radiologists in Korea [4,5].
The authors also showed that the complication rate was
6.6%, being less than that of another report by interventional
radiologists in one of the largest centers in Korea [3,5]. A
comparison, however, could be made as complications were
both listed (local infection, arterial wall injury, dissection,
thromboemboli, ﬁstulas, hematoma, acute occlusion, perfora-
tion, vasospasm, renal failure, stroke, myocardial infarct, etc.)
and graded [6]. The authors did not describe complications
according to the reporting standards of the Society of Inter-
ventional Radiology (SIR), although the authors mentioned132/$ - see front matter Copyright & 2015. The Korean Society of Nep
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dx.doi.org/10.1016/j.krcp.2015.04.001accordance with the SIR categories in the methods section.
Did the authors count and grade hematomas, which may be
the most common complication following the endovascular
procedures? This appears to be neglected when counting
minor complications in the SIR categories. Finally, parameters
showing timed components of procedures such as mean
procedure times and mean ﬂuoroscopy times should be
addressed to determine the effectiveness and safety.Conﬂict of interest
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We appreciate your interest in our recent article entitled
“Clinical outcome of percutaneous thrombectomy of dialysis
access thrombosis by an interventional nephrologist” [1].
Despite the outcomes of the current study exceeding the
guidelines of the Kidney Disease Dialysis Outcomes Quality
Initiative [2], the success rate was less than that expected in
comparison with representative studies previously reported in
the US and Korea [3,4]. Nevertheless, the principle we tried to
maintain was that thrombectomy with surgical repair should
be placed ahead of stent deployment with percutaneous
balloon angioplasty when a better outcome and longer
patency could be achieved by surgical revision such as graft
interposition or extension. We withdrew percutaneous inter-
ventions when stent placement was necessary to treat steno-
sis, and surgical revision was the preferred option on a long-
term basis. These withdrawn cases were regarded as technical
failures according to the intention-to-treat principle, explain-
ing why both the success rate and stent deployment rate were
relatively lower than other studies.
Over the study period, all complications were inspected and
we classiﬁed the complications into minor and major in
accordance with the criteria from the Society of Interventional
Radiology [5]. We performed balloon tamponade for minor
venous dissection, and percutaneous embolectomy for distal
arterial embolization as described in the article [1]. This
description means that the severity of these complications
corresponds to Grade 2. There were no complications such as
access site hematoma, most likely because we did not
approach via the brachial artery, and purse string suture was
performed at the introducer site in most cases.
The main purpose of our study was to present that the
outcome of endovascular procedures by an interventional
nephrologist was also effective and safe. The effectiveness
and safety were most likely produced by avoiding unnecessarydelays in declotting procedures and the lower level of com-
plication rate. We agree with your opinion that the mean
procedure time and mean ﬂuoroscopy time are very important
parameters to be inspected. Along with the increasing number
of dialysis access procedures performed by interventional
nephrologists, further studies will be needed to demonstrate
the risk of radiation exposure to patients and medical staff.
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